Bioxyne Ltd News

Bioxyne to Release Shares From Escrow; Shares Up 17%

Bioxyne (ASX:BXN) said 1.23 billion of its ordinary shares will be released from escrow on May 19. Major shareholders holding 1 billion shares agreed to a further 12-month voluntary escrow to May 19,

MT NewswiresMay 14 02:11 ET

Bioxyne to Raise AU$1.45 Million via Share Issuance

Bioxyne (ASX:BXN) received firm commitments to raise AU$1.45 million through the issuance of 145 million new shares at AU$0.01 apiece, according to a Thursday filing with the Australian bourse. The is

MT NewswiresApr 17 20:16 ET

Stocks of the Hour: Dotz Nano, Bioxyne, Castle Minerals, Linius Technologies

Dotz Nano (ASX:DTZ) has secured up to $12 million in funding with the Mercer Street Global Opportunity Fund, a US-based investment fund managed by Mercer Street Capital Partners. The funds raised will

sharecafeFeb 4 19:50 ET

Bioxyne Receives License to Manufacture Medical Cannabis, MDMA; Shares Up 50%

Health and wellness products company Bioxyne (ASX:BXN), through its subsidiary Breathe Life Sciences, has been awarded a Good Manufacturing Practice license to manufacture medical cannabis. The licens

MT NewswiresFeb 4 19:09 ET

Bioxyne Unit Joins Forces to Launch B2B Cannabis Trading Platform in Australia; Shares Slump 11%

Bioxyne's (ASX:BXN) subsidiary, Breathe Life Sciences, partnered with technology firm CanXChange to launch a business-to-business wholesale trading platform in Australia slated to go live by the fourt

MT NewswiresAug 15, 2023 01:25 ET